Tysabri for Multiple Sclerosis

Links shared publicly online about this topic

Incidence Of PML With Tysabri In Multiple Sclerosis Lower Than Previously Thought

medicalnewstoday.com — “The risk of developing progressive multifocal leukoencephalopathy (PML), a viral brain infection, in patients with multiple sclerosis (MS) taking the drug natalizumab (Tysabri) appears to be much View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 8, 2009 at 2:37 pm By:

LisaEmrich Lisa Emrich Patient Expert

MedNewsToday: Incidence Of PML With Tysabri In Multiple Sclerosis Lower Than Previously Thought: Th.. http://tinyurl.com/re7kp3

3 years ago...

Results Further Support The Benefits Of TYSABRI For Multiple Sclerosis Patients

medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) have announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 14, 2009 at 10:12 am By:

psychiatry_md psychiatryrounds Psychiatry and Support

Results Further Support The Benefits Of TYSABRI For Multiple Sclerosis Patients: Biogen Idec (NASDAQ: BIIB) and .. http://bit.ly/jkuoc

3 years ago...

Biogen Idec introduces Tysabri for multiple sclerosis - World News, 111989

newkerala.com — “Biogen Idec introduces Tysabri for multiple sclerosis - Mumbai, Dec 24 : Biogen Idec has, a leading drug manufacturer, has announced the introduction of Tysabri (natalizumab) the first humanized, monoclonal antibody for the treatment of relapsing remitting multiple sclerosis (MS) in India.View full resource at newkerala.com

  • View Related
  • Share

Most Recently Shared on December 24, 2010 at 10:29 pm By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Biogen Idec introduces Tysabri for multiple sclerosis: Mumbai, Dec 24 : Biogen Idec has, a leading drug manufact... http://bit.ly/i4woPc

1 year ago...

Results Further Support The Benefits Of TYSABRI For Multiple Sclerosis Patients | Psydir News

news.psydir.com — “Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) have announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI (natalizumab) experienced an improvement in both their physical function and psychological well-being. Findings from the study, which was performed in conjunct...View full resource at news.psydir.com

  • View Related
  • Share

Most Recently Shared on September 14, 2009 at 12:32 pm By:

psydir PsyDir News Health News

Results Further Support The Benefits Of TYSABRI For Multiple Sclerosis Patients http://ow.ly/15OWal

3 years ago...

Provenge for Prostate Cancer, Tysabri for Multiple Sclerosis - Health Blog - WSJ

blogs.wsj.com — “Dendreon is building manufacturing facilities for a prostate cancer treatment that has yet to be approved. Biogen Idec says its multiple sclerosis drug entered blockbuster territory.View full resource at blogs.wsj.com

  • View Related
  • Share

Most Recently Shared on January 12, 2010 at 4:37 pm By:

knoxvillehosp Knoxville Hospital Hospital

Biotech News: Provenge for Prostate Cancer, Tysabri for M.S.: J.P. Morgan is hosting its big drug-industry confere... http://bit.ly/7oINnU

2 years ago...

MS News From the AAN Meetings: Significant Risks From Tysabri Identified - Multiple Sclerosis Blog

everydayhealth.com — “Alfred Sandrock, MD, PhD, of Biogen/Idec, presented findings from the company--™s study on progressive multifocal leukoencephalopathy (PML) in patients using Biogen/Idec--™s MS drug, Tysabri --" a drug that has garnered the name --poison-- from some critics.View full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on April 20, 2011 at 6:54 pm By:

Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore | Xconomy

xconomy.com — “Few doctors knew much about a rare brain infection called PML back in 2005, when two patients on a hot new multiple sclerosis drug from Biogen Idec and ElanView full resource at xconomy.com

  • View Related
  • Share

Most Recently Shared on November 19, 2009 at 2:31 pm By:

ldtimmerman Luke Timmerman Health Communicator

Tysabri, the MS drug haunted by deadly side effect, doesn't look so deadly anymore. http://bit.ly/1RMVVN

3 years ago...

TYSABRI?

msrc.co.uk — “Tysabri (Natalizumab) Latest News page with information on the latest Tysabri (Natalizumab) news and Multiple Sclerosis Research in the MS Research News section of the Multiple Sclerosis Resource Centre (MSRC) website.View full resource at msrc.co.uk

  • View Related
  • Share

Most Recently Shared on October 22, 2011 at 8:25 pm By:

LisaEmrich Lisa Emrich Patient Expert

@jcberrypdx Or per 1000: 2.41 (1 yr or longer), 3.03 (2 yrs or longer), 1.85 (3 yrs or longer) http://t.co/CTbizWd7 scroll down to July

7 months ago...

Multiple Sclerosis Resource Centre TYSABRI

msrc.co.uk — “The home site of the Multiple Sclerosis Resource Centre, Multiple Sclerosis, Multiple Sclerosis Resource Centre, MSRC, Telephone Counselling Service, 24hour, MS, Health, Disabled, Myelin, MRI, Physically Disabled, Service, MS Drugs, MS News, Beta Interferon, Disability, MS Research, Best Bet Diet, BBD, Discussion Boards, Support, immunology, onset symptoms, warning signs, early symptoms, nutrition, symptoms, treatment, diagnosis, history, TYSABRIView full resource at msrc.co.uk

  • View Related
  • Share

Most Recently Shared on October 21, 2009 at 10:06 am By:

georgejelinek George Jelinek Doctor, Emergency Physician, and Physician

RT @MSRC Tysabri MS patient develops brain cancer (primary central nervous system lymphoma) - http://tinyurl.com/633jam

3 years ago...

Multiple Sclerosis Resource Centre TYSABRI

msrc.co.uk — “The home site of the Multiple Sclerosis Resource Centre, Multiple Sclerosis, Multiple Sclerosis Resource Centre, MSRC, Telephone Counselling Service, 24hour, MS, Health, Disabled, Myelin, MRI, Physically Disabled, Service, MS Drugs, MS News, Beta Interferon, Disability, MS Research, Best Bet Diet, BBD, Discussion Boards, Support, immunology, onset symptoms, warning signs, early symptoms, nutrition, symptoms, treatment, diagnosis, history, TYSABRIView full resource at msrc.co.uk

  • View Related
  • Share

Most Recently Shared on June 22, 2010 at 7:43 am By:

A New Place to Discuss Tysabri - Multiple Sclerosis Blog

everydayhealth.com — “Our posts about the MS drug Tysabri have been some of the most active on the blog. One Tysabri posting in particular having over 1,400 comments!View full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on October 28, 2010 at 12:39 am By:

EverydayHealth Everyday Health Health Site

MS Blog Update: A New Place to Discuss Tysabri - Our posts about the MS drug Tysabri have been some of the most acti... http://ht.ly/19FFEA

2 years ago...

MS Newsmakers Series: Tysabri 6-Years On - Multiple Sclerosis Blog

everydayhealth.com — “As one new oral therapy drug for MS makes its way to the world market and another, Cladribine Novaplus (Cladribine), stumbles in approval proceedings, many of our readers still have questions about Tysabri (Natalizumab).View full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on October 22, 2010 at 12:39 am By:

EverydayHealth Everyday Health Health Site

MS Blog Update: MS Newsmakers Series: Tysabri 6-Years On - As one new oral therapy drug for MS makes its way to the ... http://ht.ly/19zB5G

2 years ago...

Tysabri (natalizumab), PML (progressive multifocal leukoencephalopathy), and Ongoing Research - Multiple Sclerosis

healthcentral.com — “Of the available disease-modifying treatments for multiple sclerosis, Tysabri (natalizumab) has arguably been the most controversial to date.  The reason f...View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on December 17, 2010 at 2:27 am By:

LisaEmrich Lisa Emrich Patient Expert

Tysabri (natalizumab), PML (progressive multifocal leukoencephalopathy), and Ongoing Research http://ow.ly/1ausyL

1 year ago...

Multiple Sclerosis - Tysabri in the News with 24th Case of PML

healthcentral.com — “Tysabri has been in the news again this week.  Last Friday the European Medicines Agency (EMEA) announced that they would review the benefits and risks for...View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on October 29, 2009 at 8:19 pm By:

LisaEmrich Lisa Emrich Patient Expert

Tysabri in the News with 24th Case of PML: Tysabri has been in the news again this week.  Last Friday the .. http://bit.ly/4vGDjQ

3 years ago...

New Information from the FDA on Tysabri - Multiple Sclerosis Blog

everydayhealth.com — “As if progressive multifocal leukoencephalopathy (PML) wasn’t a big enough word to get out of our mouths and a big enough concept around which to get our brains…now there’s immune reconstitution inflammatory syndrome (IRIS)!View full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on February 10, 2010 at 12:25 am By:

EverydayHealth Everyday Health Health Site

MS Blog Update: New Information from the FDA on Tysabri - As if progressive multifocal leukoencephalopathy (PML) wa... http://ow.ly/16xwUy

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • LisaEmrich

    Lisa Emrich

    Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com

    View Profile

  • psychiatry_md

    psychiatryrounds

    Professional social network for psychiatrists to discuss, share insights, collaborate, and network!

    View Profile

  • MS_Wisdom2

    OrganizedWisdom MS

    Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390